Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication

L. Hromadkova, ER. Heerdink, D. Philbert, ML. Bouvy,

. 2015 ; 69 (3) : 328-35. [pub] 20141014

Language English Country England, Great Britain

Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

OBJECTIVE: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients' beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients' beliefs about and persistence with chronic cardiovascular medication. METHODS: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire - specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. RESULTS: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9-1.5). CONCLUSION: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients' beliefs about medication among those concomitantly using psychiatric drugs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001230
003      
CZ-PrNML
005      
20170118114207.0
007      
ta
008      
170103s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ijcp.12544 $2 doi
024    7_
$a 10.1111/ijcp.12544 $2 doi
035    __
$a (PubMed)25311143
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hromadkova, L $u Department of Clinical Pharmacy, Hospital Na Homolce, Prague, Czech Republic; Division Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
245    10
$a Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication / $c L. Hromadkova, ER. Heerdink, D. Philbert, ML. Bouvy,
520    9_
$a OBJECTIVE: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients' beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients' beliefs about and persistence with chronic cardiovascular medication. METHODS: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire - specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. RESULTS: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9-1.5). CONCLUSION: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients' beliefs about medication among those concomitantly using psychiatric drugs.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a antipsychotika $x terapeutické užití $7 D014150
650    _2
$a kardiovaskulární látky $x terapeutické užití $7 D002317
650    _2
$a kardiovaskulární nemoci $x komplikace $x farmakoterapie $7 D002318
650    _2
$a průřezové studie $7 D003430
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zdraví - znalosti, postoje, praxe $7 D007722
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a adherence k farmakoterapii $x statistika a číselné údaje $7 D055118
650    _2
$a lidé středního věku $7 D008875
650    _2
$a psychotické poruchy $x komplikace $x farmakoterapie $7 D011618
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Heerdink, E R
700    1_
$a Philbert, D
700    1_
$a Bouvy, M L
773    0_
$w MED00004893 $t International journal of clinical practice $x 1742-1241 $g Roč. 69, č. 3 (2015), s. 328-35
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25311143 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170118114314 $b ABA008
999    __
$a ok $b bmc $g 1180370 $s 961797
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 69 $c 3 $d 328-35 $e 20141014 $i 1742-1241 $m International journal of clinical practice $n Int J Clin Pract $x MED00004893
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...